Why Is LEVI Stock Down Today: Tariff Costs Offset Forecast Raise
Levi shares fell over 7% as tariff costs overshadowed a higher full-year profit forecast and solid denim demand.
BTC$65,657.00+2.02%
ETH$1,717.06+2.41%
USDT$0.9993-0.03%
USDC$0.9997-0.01%
XRP$1.18+3.20%
SOL$70.92+3.48%
TRX$0.3207+1.62%
FIGR_HELOC$1.02+0.00%
HYPE$64.83+7.69%
DOGE$0.0886+1.27%
USDS$0.9997-0.01%
LEO$9.78+0.33%
RAIN$0.0136+4.26%
ZEC$486.93+15.45%
ADA$0.1799+4.75%
BTC$65,657.00+2.02%
ETH$1,717.06+2.41%
USDT$0.9993-0.03%
USDC$0.9997-0.01%
XRP$1.18+3.20%
SOL$70.92+3.48%
TRX$0.3207+1.62%
FIGR_HELOC$1.02+0.00%
HYPE$64.83+7.69%
DOGE$0.0886+1.27%
USDS$0.9997-0.01%
LEO$9.78+0.33%
RAIN$0.0136+4.26%
ZEC$486.93+15.45%
ADA$0.1799+4.75%
NVIDIA stock rose nearly 4% premarket after Trump eased his China tariff stance, boosting chipmakers and big tech stocks.
Levi shares fell over 7% as tariff costs overshadowed a higher full-year profit forecast and solid denim demand.
Applied Digital stock soared after strong Q1 results and a major $11 billion AI lease deal with CoreWeave.
Serve Robotics shares climbed over 12% in premarket on news of a new DoorDash partnership for autonomous deliveries.
Joby Aviation stock fell in premarket trading after announcing a $514 million share offering to fund certification and launch plans.
IBM stock climbed 7% in premarket trading after announcing a deal with Anthropic to bring Claude AI to its software suite.
IREN stock climbed in premarket after announcing new AI cloud deals and GPU deployments targeting over $500 million in 2026 revenue.
APP shares dropped after reports of an SEC probe into its data practices and potential breaches of platform agreements.
CRML stock surged after reports the U.S. may take a stake in its Greenland rare earths project.
AMD stock climbed over 20% after announcing a major AI chip partnership with OpenAI.
Plug Power stock surged over 250% since May on analyst upgrades and record hydrogen output.
USAR shares jumped after CEO confirmed White House talks, topping $25 in premarket trading.
ANRO stock rose over 6% in premarket after the FDA granted Fast Track status to ALTO-101, its schizophrenia drug candidate.